Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A Phase 2 Randomized Double-Blind Placebo-Controlled Dose-Ranging Study to Assess the Safety and Efficacy of VP 20621 for Prevention of Recurrence of Clostridium Difficile Infection (CDI) in Adult Patients Previously Treated for CDI
Greenberg, Richard
(PI)
Internal Medicine
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
10/7/11
→
2/28/14
Funding
ViroPharma Inc:
$45,650.00
View all
View less